approved EB-2 (NIW)

Postdoc

Natural Product Chemistry · Vietnam · 2025-01-11

Processing Time
278 days
Decision Date
2025-01-11
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to identify and analyze novel bioactive compounds isolated from natural sources with distinct chemical diversity. This work aims to accelerate the development of new pharmaceuticals for chronic diseases that currently lack adequate treatments, such as diabetes, cardiovascular disease, and osteoporosis.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses unmet medical needs and promotes innovation in drug discovery for chronic diseases, aligning with national healthcare priorities.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 11 publications, 145 citations, and history of securing major international funding demonstrates their ability to advance the field.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner's specialized expertise in natural product chemistry and the potential impact on global health and U.S. pharmaceutical innovation justify the waiver.

Why This Petition Was Approved

The petitioner submitted evidence of 11 peer-reviewed journal publications (including four first-authored and two co-first-authored works) and two first-authored conference abstracts. These works accumulated 145 citations, demonstrating high regard in the field. The case was further supported by a Pharm.D. degree and a history of international funding from the National Research Foundation (NRF) and the Ministry of Education, Korea.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Grants
Original Contributions

Similar Cases

Scientist

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 69 days 2022-04-19
The petitioner proposes to continue analyzing synthetic routes to isolate, synthesize, design, and ensure the safety of novel drug molecules. This work is part of innovative drug discovery projects aimed at treating cancer, heart disease, and infectious diseases to improve global and U.S. healthcare outcomes.

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.

Postdoctoral Researcher

Research and Development · Mexico

WeGreened EB-2 (NIW) approved
Colorado 425 days 2022-03-26
The petitioner proposes to synthesize and test novel compounds designed to stabilize HIF transcription factors. This work aims to develop new therapeutic applications for the treatment of inflammatory diseases and to improve wound healing processes.

Postdoctoral Researcher

Research and Development · Nigeria

WeGreened EB-2 (NIW) approved
South Africa 74 days 2023-02-27
The petitioner proposes to identify natural product drug candidates to develop therapeutics for the management of degenerative diseases such as cancer, diabetes mellitus, and HIV/AIDS. The work focuses on reducing the prevalence of these conditions through molecular biology-related DNA quantification and sequencing of indigenous medicinal plants.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-11.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 278 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist